APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA Microarray

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Selected research

Market Analysis & Forecast

Global DNA Microarray Market Analysis and Forecast 2026-2032

Report ID 173894040222 December 2025192 pages

Choose your research edition.

Industry ResearchDNA Microarray Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Microarray Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal DNA Microarray Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Microarray Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Microarray Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

A microarray is a tiny, bio-compatible silicon chip capable of rapid identification and precise multiplexed analysis of nucleic acids (DNA/RNA).

Global DNA Microarray key players include Illumnia, Inc, Affymetrix, Agilent Technologies, etc. Global top three manufacturers hold a share about 55%.

USA is the largest market, with a share over 90%, followed by Europe and Others, both have a share over 5 percent.

Read the full market overview

In terms of product, Oligonucleotide DNA Microarrays (oDNA) is the largest segment, with a share over 95%. And in terms of application, the largest application is Gene Expression, followed by Genotyping.

Report Includes

This report presents an overview of global market for DNA Microarray, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA Microarray, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Microarray, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA Microarray revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Microarray market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Microarray revenue, projected growth trends, production technology, application and end-user industry.

DNA Microarray Segment by Company

Illumnia

Affymetrix

Agilent Technologies

Roche NimbleGen

Sengenics

Arrayit

Applied Microarrays

Biometrix Technology

Savyon Diagnostics

Scienion AG

WaferGen

DNA Microarray Segment by Type

Oligonucleotide DNA Microarrays (oDNA)

Complementary DNA Microarrays (cDNA)

DNA Microarray Segment by Application

Gene Expression

Genotyping

Other Usage

Genome Cytogenetics

DNA Microarray Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Microarray market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Microarray and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Microarray.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of DNA Microarray in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of DNA Microarray company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Microarray revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global DNA Microarray Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oligonucleotide DNA Microarrays (oDNA) Major Player Table 3. Complementary DNA Microarrays (cDNA) Major Player Table 4. Global DNA Microarray Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Gene Expression Major Player Table 6. Genotyping Major Player Table 7. Other Usage Major Player Table 8. Genome Cytogenetics Major Player Table 9. DNA Microarray Industry Trends Table 10. DNA Microarray Industry Drivers Table 11. DNA Microarray Industry Opportunities and Challenges Table 12. DNA Microarray Industry Restraints Table 13. Global DNA Microarray Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global DNA Microarray Market Size by Region (2021-2026) & (US$ Million) Table 15. Global DNA Microarray Market Share by Region (2021-2026) Table 16. Global DNA Microarray Market Size by Region (2027-2032) & (US$ Million) Table 17. Global DNA Microarray Market Share by Region (2027-2032) Table 18. Global DNA Microarray Revenue by Players (US$ Million) & (2021-2026) Table 19. Global DNA Microarray Revenue Market Share by Players (2021-2026) Table 20. Global DNA Microarray Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global DNA Microarray Key Players Headquarters & Area Served Table 22. Global DNA Microarray Players, Product Type & Application Table 23. Global DNA Microarray Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global DNA Microarray by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global DNA Microarray Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 28. Global DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 29. Global DNA Microarray Revenue Market Share by Type (2021-2026) Table 30. Global DNA Microarray Revenue Market Share by Type (2027-2032) Table 31. Global DNA Microarray Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 33. Global DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 34. Global DNA Microarray Revenue Market Share by Application (2021-2026) Table 35. Global DNA Microarray Revenue Market Share by Application (2027-2032) Table 36. Illumnia Company Information Table 37. Illumnia Business Overview Table 38. Illumnia DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Illumnia DNA Microarray Product Portfolio Table 40. Illumnia Recent Development Table 41. Affymetrix Company Information Table 42. Affymetrix Business Overview Table 43. Affymetrix DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Affymetrix DNA Microarray Product Portfolio Table 45. Affymetrix Recent Development Table 46. Agilent Technologies Company Information Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Agilent Technologies DNA Microarray Product Portfolio Table 50. Agilent Technologies Recent Development Table 51. Roche NimbleGen Company Information Table 52. Roche NimbleGen Business Overview Table 53. Roche NimbleGen DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Roche NimbleGen DNA Microarray Product Portfolio Table 55. Roche NimbleGen Recent Development Table 56. Sengenics Company Information Table 57. Sengenics Business Overview Table 58. Sengenics DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Sengenics DNA Microarray Product Portfolio Table 60. Sengenics Recent Development Table 61. Arrayit Company Information Table 62. Arrayit Business Overview Table 63. Arrayit DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Arrayit DNA Microarray Product Portfolio Table 65. Arrayit Recent Development Table 66. Applied Microarrays Company Information Table 67. Applied Microarrays Business Overview Table 68. Applied Microarrays DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Applied Microarrays DNA Microarray Product Portfolio Table 70. Applied Microarrays Recent Development Table 71. Biometrix Technology Company Information Table 72. Biometrix Technology Business Overview Table 73. Biometrix Technology DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Biometrix Technology DNA Microarray Product Portfolio Table 75. Biometrix Technology Recent Development Table 76. Savyon Diagnostics Company Information Table 77. Savyon Diagnostics Business Overview Table 78. Savyon Diagnostics DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Savyon Diagnostics DNA Microarray Product Portfolio Table 80. Savyon Diagnostics Recent Development Table 81. Scienion AG Company Information Table 82. Scienion AG Business Overview Table 83. Scienion AG DNA Microarray Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Scienion AG DNA Microarray Product Portfolio Table 85. Scienion AG Recent Development Table 86. WaferGen Company Information Table 87. WaferGen Business Overview Table 88. WaferGen DNA Microarray Sales (k units), Revenue (US$ Million), Price (M USD) and Gross Margin (2021-2026) Table 89. WaferGen DNA Microarray Product Portfolio Table 90. WaferGen Recent Development Table 91. North America DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 92. North America DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 93. North America DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 94. North America DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 95. North America DNA Microarray Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America DNA Microarray Revenue by Country (2021-2026) & (US$ Million) Table 97. North America DNA Microarray Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe DNA Microarray Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe DNA Microarray Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe DNA Microarray Revenue by Country (US$ Million) & (2027-2032) Table 105. China DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 106. China DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 107. China DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 108. China DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia DNA Microarray Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia DNA Microarray Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia DNA Microarray Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA DNA Microarray Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA DNA Microarray Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA DNA Microarray Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA DNA Microarray Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA DNA Microarray Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA DNA Microarray Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA DNA Microarray Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. DNA Microarray Image Figure 2. Global DNA Microarray Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Microarray Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oligonucleotide DNA Microarrays (oDNA) Image Figure 5. Complementary DNA Microarrays (cDNA) Image Figure 6. Global DNA Microarray Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global DNA Microarray Market Size Share 2021 VS 2025 VS 2032 Figure 8. Gene Expression Image Figure 9. Genotyping Image Figure 10. Other Usage Image Figure 11. Genome Cytogenetics Image Figure 12. Global DNA Microarray Market Size (US$ Million) & (2021-2032) Figure 13. Global DNA Microarray Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global DNA Microarray Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global DNA Microarray Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global DNA Microarray Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global DNA Microarray Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global DNA Microarray Revenue Market Share by Type (2021-2032) Figure 20. Global DNA Microarray Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global DNA Microarray Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global DNA Microarray Revenue Market Share by Application (2021-2032) Figure 23. North America DNA Microarray Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America DNA Microarray Revenue Share by Type (2021-2032) Figure 25. North America DNA Microarray Revenue Share by Application (2021-2032) Figure 26. North America DNA Microarray Revenue Share by Country (2021-2032) Figure 27. United States DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe DNA Microarray Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe DNA Microarray Revenue Share by Type (2021-2032) Figure 32. Europe DNA Microarray Revenue Share by Application (2021-2032) Figure 33. Europe DNA Microarray Revenue Share by Country (2021-2032) Figure 34. Germany DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China DNA Microarray Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China DNA Microarray Revenue Share by Type (2021-2032) Figure 44. China DNA Microarray Revenue Share by Application (2021-2032) Figure 45. Asia DNA Microarray Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia DNA Microarray Revenue Share by Type (2021-2032) Figure 47. Asia DNA Microarray Revenue Share by Application (2021-2032) Figure 48. Asia DNA Microarray Revenue Share by Region (2021-2032) Figure 49. Japan DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA DNA Microarray Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA DNA Microarray Revenue Share by Type (2021-2032) Figure 57. SAMEA DNA Microarray Revenue Share by Application (2021-2032) Figure 58. SAMEA DNA Microarray Revenue Share by Country (2021-2032) Figure 59. Brazil DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt DNA Microarray Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oligonucleotide DNA Microarrays (oDNA)
  • Complementary DNA Microarrays (cDNA)
Applications
  • Gene Expression
  • Genotyping
  • Other Usage
  • Genome Cytogenetics
Companies covered
  • Illumnia
  • Affymetrix
  • Agilent Technologies
  • Roche NimbleGen
  • Sengenics
  • Arrayit
  • Applied Microarrays
  • Biometrix Technology
  • Savyon Diagnostics
  • Scienion AG
  • WaferGen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 DNA Microarray Market by Type
  3. 1.2.1 Global DNA Microarray Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oligonucleotide DNA Microarrays (oDNA)
  5. 1.2.3 Complementary DNA Microarrays (cDNA)
  6. 1.3 DNA Microarray Market by Application
  7. 1.3.1 Global DNA Microarray Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Gene Expression
  9. 1.3.3 Genotyping
  10. 1.3.4 Other Usage
  11. 1.3.5 Genome Cytogenetics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 DNA Microarray Market Dynamics
  1. 2.1 DNA Microarray Industry Trends
  2. 2.2 DNA Microarray Industry Drivers
  3. 2.3 DNA Microarray Industry Opportunities and Challenges
  4. 2.4 DNA Microarray Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global DNA Microarray Market Perspective (2021-2032)
  2. 3.2 Global DNA Microarray Growth Trends by Region
  3. 3.2.1 Global DNA Microarray Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global DNA Microarray Market Size by Region (2021-2026)
  5. 3.2.3 Global DNA Microarray Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global DNA Microarray Revenue by Players
  2. 4.1.1 Global DNA Microarray Revenue by Players (2021-2026)
  3. 4.1.2 Global DNA Microarray Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global DNA Microarray Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global DNA Microarray Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global DNA Microarray Key Players Headquarters & Area Served
  7. 4.4 Global DNA Microarray Players, Product Type & Application
  8. 4.5 Global DNA Microarray Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global DNA Microarray Market CR5 and HHI
  11. 4.6.3 2025 DNA Microarray Tier 1, Tier 2, and Tier 3
5 DNA Microarray Market Size by Type
  1. 5.1 Global DNA Microarray Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global DNA Microarray Revenue by Type (2021-2032)
  3. 5.3 Global DNA Microarray Revenue Market Share by Type (2021-2032)
6 DNA Microarray Market Size by Application
  1. 6.1 Global DNA Microarray Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global DNA Microarray Revenue by Application (2021-2032)
  3. 6.3 Global DNA Microarray Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumnia
  2. 7.1.1 Illumnia Company Information
  3. 7.1.2 Illumnia Business Overview
  4. 7.1.3 Illumnia DNA Microarray Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumnia DNA Microarray Product Portfolio
  6. 7.1.5 Illumnia Recent Developments
  7. 7.2 Affymetrix
  8. 7.2.1 Affymetrix Company Information
  9. 7.2.2 Affymetrix Business Overview
  10. 7.2.3 Affymetrix DNA Microarray Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Affymetrix DNA Microarray Product Portfolio
  12. 7.2.5 Affymetrix Recent Developments
  13. 7.3 Agilent Technologies
  14. 7.3.1 Agilent Technologies Company Information
  15. 7.3.2 Agilent Technologies Business Overview
  16. 7.3.3 Agilent Technologies DNA Microarray Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies DNA Microarray Product Portfolio
  18. 7.3.5 Agilent Technologies Recent Developments
  19. 7.4 Roche NimbleGen
  20. 7.4.1 Roche NimbleGen Company Information
  21. 7.4.2 Roche NimbleGen Business Overview
  22. 7.4.3 Roche NimbleGen DNA Microarray Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche NimbleGen DNA Microarray Product Portfolio
  24. 7.4.5 Roche NimbleGen Recent Developments
  25. 7.5 Sengenics
  26. 7.5.1 Sengenics Company Information
  27. 7.5.2 Sengenics Business Overview
  28. 7.5.3 Sengenics DNA Microarray Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sengenics DNA Microarray Product Portfolio
  30. 7.5.5 Sengenics Recent Developments
  31. 7.6 Arrayit
  32. 7.6.1 Arrayit Company Information
  33. 7.6.2 Arrayit Business Overview
  34. 7.6.3 Arrayit DNA Microarray Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Arrayit DNA Microarray Product Portfolio
  36. 7.6.5 Arrayit Recent Developments
  37. 7.7 Applied Microarrays
  38. 7.7.1 Applied Microarrays Company Information
  39. 7.7.2 Applied Microarrays Business Overview
  40. 7.7.3 Applied Microarrays DNA Microarray Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Applied Microarrays DNA Microarray Product Portfolio
  42. 7.7.5 Applied Microarrays Recent Developments
  43. 7.8 Biometrix Technology
  44. 7.8.1 Biometrix Technology Company Information
  45. 7.8.2 Biometrix Technology Business Overview
  46. 7.8.3 Biometrix Technology DNA Microarray Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Biometrix Technology DNA Microarray Product Portfolio
  48. 7.8.5 Biometrix Technology Recent Developments
  49. 7.9 Savyon Diagnostics
  50. 7.9.1 Savyon Diagnostics Company Information
  51. 7.9.2 Savyon Diagnostics Business Overview
  52. 7.9.3 Savyon Diagnostics DNA Microarray Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Savyon Diagnostics DNA Microarray Product Portfolio
  54. 7.9.5 Savyon Diagnostics Recent Developments
  55. 7.10 Scienion AG
  56. 7.10.1 Scienion AG Company Information
  57. 7.10.2 Scienion AG Business Overview
  58. 7.10.3 Scienion AG DNA Microarray Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Scienion AG DNA Microarray Product Portfolio
  60. 7.10.5 Scienion AG Recent Developments
  61. 7.11 WaferGen
  62. 7.11.1 WaferGen Company Information
  63. 7.11.2 WaferGen Business Overview
  64. 7.11.3 WaferGen DNA Microarray Revenue and Gross Margin (2021-2026)
  65. 7.11.4 WaferGen DNA Microarray Product Portfolio
  66. 7.11.5 WaferGen Recent Developments
8 North America
  1. 8.1 North America DNA Microarray Revenue (2021-2032)
  2. 8.2 North America DNA Microarray Revenue by Type (2021-2032)
  3. 8.2.1 North America DNA Microarray Revenue by Type (2021-2026)
  4. 8.2.2 North America DNA Microarray Revenue by Type (2027-2032)
  5. 8.3 North America DNA Microarray Revenue Share by Type (2021-2032)
  6. 8.4 North America DNA Microarray Revenue by Application (2021-2032)
  7. 8.4.1 North America DNA Microarray Revenue by Application (2021-2026)
  8. 8.4.2 North America DNA Microarray Revenue by Application (2027-2032)
  9. 8.5 North America DNA Microarray Revenue Share by Application (2021-2032)
  10. 8.6 North America DNA Microarray Revenue by Country
  11. 8.6.1 North America DNA Microarray Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America DNA Microarray Revenue by Country (2021-2026)
  13. 8.6.3 North America DNA Microarray Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe DNA Microarray Revenue (2021-2032)
  2. 9.2 Europe DNA Microarray Revenue by Type (2021-2032)
  3. 9.2.1 Europe DNA Microarray Revenue by Type (2021-2026)
  4. 9.2.2 Europe DNA Microarray Revenue by Type (2027-2032)
  5. 9.3 Europe DNA Microarray Revenue Share by Type (2021-2032)
  6. 9.4 Europe DNA Microarray Revenue by Application (2021-2032)
  7. 9.4.1 Europe DNA Microarray Revenue by Application (2021-2026)
  8. 9.4.2 Europe DNA Microarray Revenue by Application (2027-2032)
  9. 9.5 Europe DNA Microarray Revenue Share by Application (2021-2032)
  10. 9.6 Europe DNA Microarray Revenue by Country
  11. 9.6.1 Europe DNA Microarray Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe DNA Microarray Revenue by Country (2021-2026)
  13. 9.6.3 Europe DNA Microarray Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China DNA Microarray Revenue (2021-2032)
  2. 10.2 China DNA Microarray Revenue by Type (2021-2032)
  3. 10.2.1 China DNA Microarray Revenue by Type (2021-2026)
  4. 10.2.2 China DNA Microarray Revenue by Type (2027-2032)
  5. 10.3 China DNA Microarray Revenue Share by Type (2021-2032)
  6. 10.4 China DNA Microarray Revenue by Application (2021-2032)
  7. 10.4.1 China DNA Microarray Revenue by Application (2021-2026)
  8. 10.4.2 China DNA Microarray Revenue by Application (2027-2032)
  9. 10.5 China DNA Microarray Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia DNA Microarray Revenue (2021-2032)
  2. 11.2 Asia DNA Microarray Revenue by Type (2021-2032)
  3. 11.2.1 Asia DNA Microarray Revenue by Type (2021-2026)
  4. 11.2.2 Asia DNA Microarray Revenue by Type (2027-2032)
  5. 11.3 Asia DNA Microarray Revenue Share by Type (2021-2032)
  6. 11.4 Asia DNA Microarray Revenue by Application (2021-2032)
  7. 11.4.1 Asia DNA Microarray Revenue by Application (2021-2026)
  8. 11.4.2 Asia DNA Microarray Revenue by Application (2027-2032)
  9. 11.5 Asia DNA Microarray Revenue Share by Application (2021-2032)
  10. 11.6 Asia DNA Microarray Revenue by Country
  11. 11.6.1 Asia DNA Microarray Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia DNA Microarray Revenue by Country (2021-2026)
  13. 11.6.3 Asia DNA Microarray Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA DNA Microarray Revenue (2021-2032)
  2. 12.2 SAMEA DNA Microarray Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA DNA Microarray Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA DNA Microarray Revenue by Type (2027-2032)
  5. 12.3 SAMEA DNA Microarray Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA DNA Microarray Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA DNA Microarray Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA DNA Microarray Revenue by Application (2027-2032)
  9. 12.5 SAMEA DNA Microarray Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA DNA Microarray Revenue by Country
  11. 12.6.1 SAMEA DNA Microarray Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA DNA Microarray Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA DNA Microarray Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst